KPV Alpha 10mg

KPV is the C-terminal Lysine-Proline-Valine tripeptide of α-melanocyte-stimulating hormone (α-MSH) and retains a substantial portion of the parent peptide's anti-inflammatory activity in a markedly smaller scaffold. It modulates NF-κB signalling and downstream pro-inflammatory cytokine output, making it a frequent probe in mucosal inflammation, epithelial barrier and immune-cell research. The 10mg presentation supports a full laboratory characterisation programme.

Supplied as a lyophilised peptide vial for reconstitution with bacteriostatic water. The 10mg loading suits extended in vitro cytokine assays, epithelial co-culture work and multi-condition immune characterisation within a single, consistent lot.

Research Applications • NF-κB pathway modulation and pro-inflammatory cytokine release studies in vitro • Mucosal inflammation and intestinal epithelial barrier integrity investigation • Macrophage and T-cell immune signalling and polarisation assays • Comparative α-MSH-derived peptide pharmacology and structure-activity work

Specification • Identity: KPV / Lysine-Proline-Valine (CAS 102601-49-0) • Molecular weight: 342.43 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.